Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Bridget M Hron, MD
- Phone Number: 6173556058
- Email: bridget.hron@childrens.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital
-
Contact:
- Bridget M Hron, MD
- Phone Number: 6173551433
- Email: bridget.hron@childrens.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 1-21 years
- G-tube
- Able to tolerate bolus gastric feeds over 30 minutes
- Use of conventional enteral formula
- Undergoing impedance study for clinical purposes
Exclusion Criteria:
- History of allergy or intolerance to any component of the test diets
- History of Nissen fundoplication (participants with suspected or documented unwrapped fundoplication will be eligible for participation)
- Current use of non-invasive pressure support (continuous or bi-level positive airway pressure)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Elecare - Nourish - Real Foods Blends
Elecare for first bolus, Nourish for second bolus, Real Foods Blends for third bolus
|
Elecare Jr is a standard pediatric elemental formula
Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use
Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use
|
|
Experimental: Nourish - Real Foods Blends - Elecare
Nourish for first bolus, Real Foods Blends for second bolus, Elecare for first bolus
|
Elecare Jr is a standard pediatric elemental formula
Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use
Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use
|
|
Experimental: Real Foods Blends - Elecare - Nourish
Real Foods Blends for first bolus, Elecare for second bolus, Nourish for third bolus
|
Elecare Jr is a standard pediatric elemental formula
Nourish is a commercially prepared blenderized tube feed that is formulated for pediatric use
Real Foods Blends is a commercially prepared blenderized tube feed that is formulated for pediatric use
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reflux episodes
Time Frame: 4 hours (following feed)
|
Number of total reflux episodes (acid and non-acid) by impedance
|
4 hours (following feed)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Full column reflux episodes
Time Frame: 4 hours (following feed)
|
Total number of full-column reflux episodes by impedance
|
4 hours (following feed)
|
|
Percent of time esophageal pH < 4
Time Frame: 4 hours after feed
|
Percent of time esophageal pH < 4 by impedance
|
4 hours after feed
|
|
Average height of refluxate
Time Frame: 4 hours after feed
|
Average height of refluxate by impedance
|
4 hours after feed
|
|
Number of symptoms
Time Frame: 4 hours after feed
|
Frequency of pulmonary and gastrointestinal symptoms from questionnaires during impedance
|
4 hours after feed
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric emptying (percent of ingested contents remaining in stomach at 1 hour)
Time Frame: 1 hour
|
Gastric emptying scans by scintigraphy will be analyzed if performed for clinical reasons
|
1 hour
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Bridget M Hron, MD, Boston Children's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- IRB-P00037093
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.